Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Equity Average (2018 - 2025)

Viemed Healthcare's Equity Average history spans 8 years, with the latest figure at $139.5 million for Q4 2025.

  • For Q4 2025, Equity Average rose 8.07% year-over-year to $139.5 million; the TTM value through Dec 2025 reached $139.5 million, up 8.07%, while the annual FY2025 figure was $137.5 million, 12.08% up from the prior year.
  • Equity Average reached $139.5 million in Q4 2025 per VMD's latest filing, up from $138.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $139.5 million in Q4 2025 to a low of $82.6 million in Q1 2021.
  • Average Equity Average over 5 years is $109.2 million, with a median of $104.5 million recorded in 2023.
  • Peak YoY movement for Equity Average: skyrocketed 78.51% in 2021, then rose 3.29% in 2023.
  • A 5-year view of Equity Average shows it stood at $92.1 million in 2021, then grew by 3.7% to $95.5 million in 2022, then grew by 16.6% to $111.4 million in 2023, then grew by 15.93% to $129.1 million in 2024, then increased by 8.07% to $139.5 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Equity Average are $139.5 million (Q4 2025), $138.6 million (Q3 2025), and $139.2 million (Q2 2025).